Life Science
Due Diligence

• • •

Our team has extensive experience in evaluating therapeutics, including both small molecules and biologics, and drug discovery platforms. We provide clients the vision to build asset value by advising on:

  • Scientific Merit
  • Monetization potential
  • Path from discovery to approval, including critical path, regulatory hurdles, development costs
  • Technical merit of preclinical models
  • Human dosing potential
  • Manufactuirng strategy and timelines
  • Cost of goods relative to potential commercial price
  • Commercial potential
  • Deal structures

Develop & Manage Creative &
Feasible Development Programs

• • •

We provide a strong, cohesive management team to:

 

  • Design preclinical pharmacology/ADME/toxicology studies
  • Design clinical studies that prioritize value inflection
  • Integrate all facets of development to keep asset pogressing in focused, efficient manner toward goals
  • Solicit proposals and negotiate favorable contracts with vendors
  • Manage preclinical, manufacturing, and clinical vendors
  • Define and manage regulatory strategy and communications
  • Lead efforts in raising capital
  • Provide consistent, concise program updates to BoD
  • Determine and lead corporate strategy
  • Identify and drive potential partnering and M&A opportunities